REGENERX BIOPHARMACEUTICALS, INC.

Inactive Instrument

Other languages RegeneRx Biopharmaceuticals, Inc. Other OTC

Equities

RGRX

US75886X1081

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RegeneRx Biopharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
RegeneRx Biopharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-11
RegeneRx Biopharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	23-04-10
Thymosin Beta 4 Research Leads Toward Potential Future Anti-Aging Therapy	23-01-31
Regenerx Biopharmaceuticals, Inc. Reports New Scientific Publication of RGN-259 Phase 3 Clinical Trial Results in Patients with Neurotrophic Keratopathy	23-01-03
RegeneRx Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Regenerx Licensee Submits Special Protocol Assessment to Fda for 4Th Phase 3 Clinical Trial for Dry Eye Disease	22-10-24
RegeneRx Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12
RegeneRx Biopharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16
RegeneRx Biopharmaceuticals, Inc. Reports that Researchers Demonstrate the Therapeutic Efficacy of Thymosin Beta 4	22-05-04
RegeneRx Biopharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30
RegeneRx Biopharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	22-03-29
Researchers Confirm Thymosin Beta 4's Ability to Protect Eyes From Ethanol Injury	22-01-25
RegeneRx Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15
Regenerx Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-06
Regenerx Biopharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14
Regenerx Biopharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-02
Regenerx Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-13
Regenerx Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer